EXC vs ZTS · P/E 17, rev $24.26B vs P/E 25, rev $2.47B
Exelon Corporation (EXC) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the EXC and ZTS stock pages for the full models.
Not investment advice.